Invesco’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Invesco's MXCT Position: Q1 2026 in Review
Invesco increased its MaxCyte (MXCT) stake by 79% in Q1 2026, buying an estimated $49K and bringing the position to 119,227 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3645.
Invesco first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $386K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Invesco held 119,227 shares of MaxCyte worth $83.8K as of Q1 2026.
- Invesco bought 52,532 MaxCyte shares in Q1 2026, an estimated $49K.
- MaxCyte made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3645 holding.
- Invesco first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
- Invesco's MaxCyte position peaked at $386K in Q4 2021.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.